Array BioPharma Inc - Product Pipeline Review - 2016

Date: December 30, 2016
Pages: 71
Price:
US$ 1,500.00 US$ 1,275.00
Offer valid until September 1, 2017!
License [?]:
Publisher: Global Markets Direct
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A2A8FA832C8EN
Leaflet:

Download PDF Leaflet

Array BioPharma Inc - Product Pipeline Review - 2016

SUMMARY

Global Markets Direct’s, ‘Array BioPharma Inc - Product Pipeline Review - 2016’, provides an overview of the Array BioPharma Inc’s pharmaceutical research and development focus.

The report provides comprehensive information on the therapeutics under development by Array BioPharma Inc, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

Global Markets Direct’s report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct’s proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources. Drug profiles featured in the report undergoes periodic review following a stringent set of processes to ensure that all the profiles are updated with the latest set of information. Additionally, various dynamic tracking processes ensure that the most recent developments are captured on a real time basis.

The report helps in identifying and tracking emerging players in the market and their portfolios, enhances decision making capabilities and helps to create effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data.

SCOPE
  • The report provides a snapshot of the pipeline therapeutic landscape of Array BioPharma Inc
  • The report provides overview of Array BioPharma Inc including its business description, key facts, and locations and subsidiaries
  • The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
  • The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
  • The report assesses Array BioPharma Inc’s pipeline therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type
  • The report features Array BioPharma Inc’s out-licensed and partnered product portfolio and summarizes its dormant and discontinued projects
REASONS TO BUY
  • Evaluate Array BioPharma Inc’s strategic position with total access to detailed information on its product pipeline
  • Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of therapeutics under development for Array BioPharma Inc
  • Identify potential new clients or partners in the target demographic
  • Plan mergers and acquisitions effectively by identifying key players and it’s most promising pipeline therapeutics
  • Devise corrective measures for pipeline projects by understanding Array BioPharma Inc’s pipeline depth and focus of pipeline therapeutics
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
Introduction
Global Markets Direct Report Coverage
Array BioPharma Inc Snapshot
Array BioPharma Inc Overview
Key Facts
Array BioPharma Inc - Research and Development Overview
Key Therapeutic Areas
Array BioPharma Inc - Pipeline Review
Pipeline Products by Stage of Development
Pipeline Products - Monotherapy
Pipeline Products - Combination Treatment Modalities
Pipeline Products - Partnered Products
Partnered Products/Combination Treatment Modalities
Pipeline Products - Out-Licensed Products
Out-Licensed Products/Combination Treatment Modalities
Array BioPharma Inc - Pipeline Products Glance
Array BioPharma Inc - Late Stage Pipeline Products
Pre-Registration Products/Combination Treatment Modalities
Phase III Products/Combination Treatment Modalities
Array BioPharma Inc - Clinical Stage Pipeline Products
Phase II Products/Combination Treatment Modalities
Phase I Products/Combination Treatment Modalities
Array BioPharma Inc - Early Stage Pipeline Products
Preclinical Products/Combination Treatment Modalities
Discovery Products/Combination Treatment Modalities
Array BioPharma Inc - Drug Profiles
AR-00457679 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AR-460770 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AR-523 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
AR-786 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARRY-111 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARRY-382 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARRY-797 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
ARRY-954 - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
binimetinib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
binimetinib + encorafenib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
encorafenib - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Small Molecules for Inflammation - Drug Profile
Product Description
Mechanism Of Action
R&D Progress
Array BioPharma Inc - Pipeline Analysis
Array BioPharma Inc - Pipeline Products by Target
Array BioPharma Inc - Pipeline Products by Route of Administration
Array BioPharma Inc - Pipeline Products by Molecule Type
Array BioPharma Inc - Pipeline Products by Mechanism of Action
Array BioPharma Inc - Dormant Projects
Array BioPharma Inc - Discontinued Pipeline Products
Discontinued Pipeline Product Profiles
ARRY-797
AZD-8330
binimetinib
GDC-0425
GDC-0994
Mutant cKIT Inhibitor for GIST
rabusertib
selumetinib sulfate
Array BioPharma Inc - Company Statement
Array BioPharma Inc - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

LIST OF TABLES

Array BioPharma Inc, Key Facts
Array BioPharma Inc - Pipeline by Indication, 2016
Array BioPharma Inc - Pipeline by Stage of Development, 2016
Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
Array BioPharma Inc - Partnered Products in Pipeline, 2016
Array BioPharma Inc - Partnered Products/ Combination Treatment Modalities, 2016
Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
Array BioPharma Inc - Out-Licensed Products/ Combination Treatment Modalities, 2016
Array BioPharma Inc - Pre-Registration, 2016
Array BioPharma Inc - Phase III, 2016
Array BioPharma Inc - Phase II, 2016
Array BioPharma Inc - Phase I, 2016
Array BioPharma Inc - Preclinical, 2016
Array BioPharma Inc - Discovery, 2016
Array BioPharma Inc - Pipeline by Target, 2016
Array BioPharma Inc - Pipeline by Route of Administration, 2016
Array BioPharma Inc - Pipeline by Molecule Type, 2016
Array BioPharma Inc - Pipeline Products by Mechanism of Action, 2016
Array BioPharma Inc - Dormant Developmental Projects,2016
Array BioPharma Inc - Discontinued Pipeline Products, 2016
Array BioPharma Inc, Other Locations

LIST OF FIGURES

Array BioPharma Inc - Pipeline by Top 10 Indication, 2016
Array BioPharma Inc - Pipeline by Stage of Development, 2016
Array BioPharma Inc - Monotherapy Products in Pipeline, 2016
Array BioPharma Inc - Combination Treatment Modalities in Pipeline, 2016
Array BioPharma Inc - Partnered Products in Pipeline, 2016
Array BioPharma Inc - Out-Licensed Products in Pipeline, 2016
Array BioPharma Inc - Pipeline by Top 10 Target, 2016
Array BioPharma Inc - Pipeline Route of Administration, 2016
Array BioPharma Inc - Pipeline by Molecule Type, 2016
Array BioPharma Inc - Pipeline Products by Top 10 Mechanism of Action, 2016
Skip to top


Ask Your Question

Array BioPharma Inc - Product Pipeline Review - 2016
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: